Service: Offer For Sale

Seller Broker to the Offer for Sale by Promoters of Sterling and Wilson Renewable Energy Ltd

Deal Highlights:

  • Sterling and Wilson# is a global pure-play, end-to-end renewable solar engineering, procurement and construction (EPC) and O&M solutions provider
  • Offer was made to comply with minimum public shareholding (MPS) norms
  • Despite market volatility over past 2 weeks prior to deal launch and correction of ~3%^, the issue witnessed a healthy response from investors – Non-Retail Category was oversubscribed ~1.5x of the base offer size

Our Contribution:

  • We hand-held the Promoters through the entire process including optimal deal construct, pricing & timing of the issue and positioning the company to investors
  • This marks our 3rd deal closure in the renewables / power sector within a period of 45 days – Anzen India Energy Trust (InvIT IPO), Inox Green Energy (IPO) and Sterling and Wilson (OFS)
  • This was our second deal w.r.t Sterling and Wilson post advising Reliance Group’s acquisition of stake in the Company

*Broking Services provided through an Associate Company
#Sterling and Wilson Renewable Energy Limited (formerly known as Sterling and Wilson Solar Limited)
^Movement of Nifty 50 between 2 weeks high and low

Seller Broker for Offer for Sale (OFS) by Dhanuka Laboratories Ltd

Deal Highlights:

  • Edelweiss successfully closed the 1st capital market transaction for Orchid Pharma post its take over by Dhanuka Group
  • The OFS received an overwhelming response across all categories of Investors, a testimony to Dhanuka Lab’s ability to successfully turnaround Orchid’s business
    • Non-Retail Investors – ~2.8x; Retail – ~3.5x; Overall – ~2.9x
  • Deal was strategically launched at an attractive Floor Price leading to optimum price realization in both, Non-Retail category and Retail category at ~20% and ~30% premium respectively

Our Contribution:

  • We hand-held the Promoters throughout the process including in company positioning, valuation benchmarking and explaining the potential of Orchid Pharma to investors
  • Enabled Deal Closure in Record Timeline – ~25 days from kick-off to deal launch
  • Garnered interest from large anchor investors giving confidence to launch the trade and ensured participation from diverse investors

* By Edelweiss Securities Limited